Related Experiment Video
Updated: Mar 24, 2026

Author Spotlight: Oral Candida Diagnosis to Advance Clinical Treatment Regimen for pSS Patients
Published on: March 1, 2024
Fluconazole-Induced Type 1 Kounis Syndrome
1University of British Columbia, Vancouver, Canada.
Fluconazole, an antifungal, can rarely cause Kounis syndrome, a heart condition. This report details the first known case of fluconazole-induced Type 1 Kounis syndrome in a patient with eczema.
Area of Science:
- Cardiology
- Pharmacology
- Dermatology
Background:
- Fluconazole is a widely used antifungal agent for candidiasis.
- While generally safe, it can cause adverse effects.
- Kounis syndrome is an allergic heart condition.
Observation:
- A 42-year-old woman with severe eczema presented with an adverse reaction.
- The patient developed symptoms consistent with Type 1 Kounis syndrome.
- The reaction was attributed to fluconazole administration.
Findings:
- This case represents the first reported instance of fluconazole-induced Type 1 Kounis syndrome.
- The patient's history of severe eczema may be a contributing factor.
Implications:
- Clinicians should be aware of rare but serious adverse effects of fluconazole.
- Early recognition and management of fluconazole-induced Kounis syndrome are crucial.
- Further research may explore risk factors for this rare drug reaction.
More Related Videos
09:06Author Spotlight: Photodynamic Therapy as a Novel Approach to Induce Petite Colonies in Drug-Resistant Candida for Antifungal Research
Published on: March 29, 2024
08:48Bio-energetics Investigation of Candida albicans Using Real-time Extracellular Flux Analysis
Published on: March 19, 2019
Related Concept Videos
Hypersensitivity Reactions: Cytolytic Reactions
Drug toxicity: Idiosyncratic Reactions
Drug Toxicity: Allergic Reactions
Antifungal Agents
Fungal Phylum Microsporidia
Hypersensitivity Reactions: Immune-Complex Reactions